Tislelizumab ELISA Kit,96T,DS870068-96T,Abinscience

PRINCIPLE OF THE ASSAY This assay employs the quantitative competitive enzyme immunoassay technique. Recombinant human PD1 antigen has been pre-coated onto a microplate. Standards or samples are premixed with biotin-labeled antibody and then pipetted into the wells. Tislelizumab in the sample competitively binds to the pre-coated protein with biotin-labeled Tislelizumab. After washing away any unbound substances, Streptavidin-HRP is added to the wells. Following a wash to remove any unbound enzyme reagent, a substrate solution is added to the wells and color develops in inversely proportion to the amount of Tislelizumab bound in the initial step. The color development is stopped and the intensity of the color is measured.

Stability and Storage	The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
Detection method	Colorimetric
Sample type	Plasma, Serum
Assay type	Quantitative
Sensitivity	0.156 μg/ml
Range	0.31-5 μg/mL
Recovery	80-120%
Background
Alternative Names	BGB-A317, CAS: 1858168-59-8
Shipping	2-8 ℃
Specifications	Tislelizumab
Note	For Research Use Only.